- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2020 MJH Life Sciences and Rheumatology Network. All rights reserved.
Industry News
FDA Approves Device for Low Back Pain
July 02, 2020
The U.S. Food and Drug Administration has granted pre-market approval to Mainstay Medical Holdings for the production of an implantable neurostimulator for chronic low back pain.
Secukinumab Approved for Active Non-radiographic Axial Spondyloarthritis
June 19, 2020
Secukinumab, an IL-17a inhibitor currently approved in the United States for moderate to severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis, has been approved by the U.S. Food and Drug Administration for the treatment of active non-radiographic axial spondyloarthritis.